This antibody recognizes an extracellular epitope of CD62L, a 65-76 kDa cell surface protein, expressed by neutrophils, monocytes, and subsets of T, B, and NK cells, that interacts with specific carbohydrates exposed on activated endothelial cells.
Separation of human CD62L positive lymphocytes (red-filled) from CD62L negative lymphocytes (black-dashed) in flow cytometry surface staining of human peripheral whole blood, labeling CD62L with Anti-CD62L Antibody [DREG56] (A85891), (concentration in sample 1 µg/ml) GAM APC.
Publishing research using Anti-CD62L Antibody [DREG56] (A85891)? Please let us know so that we can list the citation on this page.
Alternative products to Anti-CD62L Antibody [DREG56] (A85891)
Recombinant humanized monoclonal antibody to CD62L for use as a research grade Aselizumab biosimilar for ELISA, Flow Cytometry, Functional Studies and in vivo Research.
Recombinant humanized monoclonal antibody to CD62L for use as a research grade Aselizumab biosimilar for ELISA, Flow Cytometry, Functional Studies and in vivo Research.